, Décret n°2006-352 du 20 mars 2006 relatif aux compléments alimentaires, 2006.

«. Vitamines, &. Minéraux, and |. Synadiet,

, « Substances à but nutritionnel ou physiologique | Synadiet

, « Plantes ou préparations de plantes | Synadiet

. «-ingrédients-d'origine-animale-non and . Synadiet,

, « Les chiffres du marché en 2018 | Synadiet

«. , Consulté le: avr, vol.19, 2020.

M. F. Marre-fournier and «. Thèse, , p.123

, Code de la santé publique -Article L5111-1, pp.5111-5112

«. Mdc and . Ca,

D. Sur,

, Arrêté du 14 juin 2006 relatif aux modalités de transmission des déclarations de première mise sur le marché des compléments alimentaires

, « Réglementation concernant la vente de compléments alimentaires

. «-l',

, Code de la consommation -Article R112-2, pp.112-114

«. Afsca--, Additifs dans les denrées alimentaires

«. ,

, Consulté le: avr, vol.19, 2020.

«. Diu-inftec_pharmacocinétique_20141121,

D. Sur,

J. Alexandre and . Principes-de-pharmacocinétique, , p.36

X. Chen, M. D. Antman, C. Gesenberg, and O. S. Gudmundsson, « Discovery pharmaceutics-Challenges and opportunities, AAPS J, vol.8, issue.2, pp.402-408, 2006.

«. Biowaivers,

D. R. Brown, L. A. Gough, S. K. Deb, S. A. Sparks, and L. R. Mcnaughton, Astaxanthin in Exercise Metabolism, Performance and Recovery: A Review, vol.4, p.76, 2017.

S. Davinelli, M. E. Nielsen, and G. Scapagnini, Astaxanthin in Skin Health, Repair, and Disease: A Comprehensive Review, vol.10, 2018.

S. Fakhri, F. Abbaszadeh, L. Dargahi, M. Jorjani, and . Astaxanthin, A mechanistic review on its biological activities and health benefits », Pharmacol. Res, vol.136, pp.1-20, 2018.

R. R. Ambati, S. M. Phang, S. Ravi, and R. G. Aswathanarayana, « Astaxanthin: sources, extraction, stability, biological activities and its commercial applications--a review, Mar Drugs, vol.12, issue.1, pp.128-152

W. Miki, Biological Functions and Activities of Animal Carotenoids, vol.63, pp.141-146, 1991.

M. Guerin, M. E. Huntley, and M. Olaizola, « Haematococcus astaxanthin: applications for human health and nutrition, Trends Biotechnol, vol.21, issue.5, pp.210-216, 2003.

P. Kidd and . Astaxanthin, cell membrane nutrient with diverse clinical benefits and anti-aging potential », Altern Med Rev, vol.16, issue.4, pp.355-364, 2011.

G. Hussein, U. Sankawa, H. Goto, K. Matsumoto, H. Watanabe et al., J. Nat. Prod, vol.69, issue.3, pp.443-449, 2006.

J. Yuan, J. Peng, K. Yin, and J. Wang, « Potential health-promoting effects of astaxanthin: a high-value carotenoid mostly from microalgae, Mol Nutr Food Res, vol.55, issue.1, pp.150-165

I. Higuera-ciapara, L. Félix-valenzuela, F. M. Goycoolea, and . Astaxanthin, Crit Rev Food Sci Nutr, vol.46, issue.2, pp.185-196, 2006.

G. Britton, « Structure and properties of carotenoids in relation to function, FASEB J, vol.9, pp.1551-1558, 1995.

R. S. Parker, « Absorption, metabolism, and transport of carotenoids », FASEB J, vol.10, issue.5, pp.542-551, 1996.

Y. Okada, M. Ishikura, and T. Maoka, « Bioavailability of astaxanthin in Haematococcus algal extract: the effects of timing of diet and smoking habits, Biosci. Biotechnol. Biochem, vol.73, issue.9, 1928.

, Scientific Opinion on the safety and efficacy of synthetic astaxanthin as feed additive for salmon and trout, other fish, EFSA Journal, vol.12, issue.6, p.3724, 2014.

, « efsa-opinion-on-the-safety-of-astaxanthin-rich-ingredients-astareal-a1010-and-astareal-l10

D. Sur,

, « Safety of an astaxanthin-rich Haematococcus pluvialis algal extract: a randomized clinical trial

, « Astaxanthin in cardiovascular health and disease: mechanisms of action, therapeutic merits, and knowledge gaps

G. A. Spiller and A. Dewell, « Safety of an astaxanthin-rich Haematococcus pluvialis algal extract: a randomized clinical trial », J Med Food, vol.6, issue.1, pp.51-56, 2003.

J. Odeberg, A. Lignell, A. Pettersson, and P. Höglund, « Oral bioavailability of the antioxidant astaxanthin in humans is enhanced by incorporation of lipid based formulations », Eur J Pharm Sci, vol.19, issue.4, pp.299-304, 2003.

V. Serebruany, A. Malinin, T. Goodin, and F. Pashkow, « The in vitro effects of Xancor, a synthetic astaxanthine derivative, on hemostatic biomarkers in aspirin-naïve and aspirin-treated subjects with multiple risk factors for vascular disease », Am J Ther, vol.17, issue.2, pp.125-132

M. M. Shah, Y. Liang, J. J. Cheng, M. Daroch, and . Astaxanthin, Producing Green Microalga Haematococcus pluvialis: From Single Cell to High Value Commercial Products, Front Plant Sci, vol.7, p.531, 2016.

L. Novoveská, M. E. Ross, M. S. Stanley, R. Pradelles, V. Wasiolek et al., « Microalgal Carotenoids: A Review of Production, Current Markets, Regulations, and Future Direction, Mar Drugs, vol.17, issue.11, 2019.

A. Rao, R. L. Raghunath-reddy, V. Baskaran, R. Sarada, and G. A. Ravishankar, « Characterization of microalgal carotenoids by mass spectrometry and their bioavailability and antioxidant properties elucidated in rat model, J. Agric. Food Chem, vol.58, pp.8553-8559, 2010.

|. «-définition, . Stress-oxydatif-|-futura, and . Santé, , 2020.

A. Kammeyer and R. M. Luiten, « Oxidation events and skin aging, Ageing Res. Rev, vol.21, pp.16-29, 2015.

, « Astaxanthin prevents changes in the activities of thioredoxin reductase and paraoxonase in hypercholesterolemic rabbits

A. Rao, V. Baskaran, R. Sarada, and G. A. Ravishankar, « In vivo bioavailability and antioxidant activity of carotenoids from microalgal biomass -A repeated dose study, Food Research International, vol.54, issue.1, pp.711-717, 2013.

S. Davinelli, M. Maes, G. Corbi, A. Zarrelli, D. C. Willcox et al., « Dietary phytochemicals and neuro-inflammaging: from mechanistic insights to translational challenges, Immun Ageing, vol.13, p.16, 2016.

, Multiple Mechanisms of Anti-Cancer Effects Exerted by Astaxanthin, vol.22, 2020.

M. Nakano, « Effect of astaxanthin in combination with alpha-tocopherol or ascorbic acid against oxidative damage in diabetic ODS rats, J. Nutr. Sci. Vitaminol, vol.54, issue.4, pp.329-334, 2008.

«. Dna-damage, Apoptosis and Langerhans cells -Activators of UV-induced Immune Tolerance, 2020.

«. Cline and P. C. Hanawalt, Who's on first in the cellular response to DNA damage?, Nat Rev Mol Cell Biol, vol.4, issue.5, pp.2003-45361, 2003.

E. Camera, canthaxanthin and beta-carotene differently affect UVAinduced oxidative damage and expression of oxidative stress-responsive enzymes, Exp. Dermatol, vol.18, issue.3, pp.222-231, 2009.

P. C. Kam and N. I. Ferch, Apoptosis: mechanisms and clinical implications », Anaesthesia, vol.55, pp.1081-1093, 2000.

L. Zhang and H. Wang, « Multiple Mechanisms of Anti-Cancer Effects Exerted by

, Mar Drugs, vol.13, pp.4310-4330, 2015.

P. Palozza, « Growth-inhibitory effects of the astaxanthin-rich alga Haematococcus pluvialis in human colon cancer cells, Cancer Lett, vol.283, issue.1, pp.108-117, 2009.

S. Hasani-ranjbar, Z. Jouyandeh, and M. Abdollahi, « A systematic review of anti-obesity medicinal plants -an update, J Diabetes Metab Disord, vol.12, issue.1, p.28, 2013.

K. Uchiyama, Y. Naito, G. Hasegawa, N. Nakamura, J. Takahashi et al., « Astaxanthin protects beta-cells against glucose toxicity in diabetic db/db mice, Redox Rep, vol.7, issue.5, pp.290-293, 2002.

G. D. Curek, Effect of astaxanthin on hepatocellular injury following ischemia/reperfusion », Toxicology, vol.267, pp.147-153

M. Shen, « Protective effect of astaxanthin on liver fibrosis through modulation of TGF-?1 expression and autophagy, Mediators Inflamm, vol.2014, p.954502, 2014.

J. Li, « Astaxanthin Inhibits Proliferation and Induces Apoptosis of Human Hepatocellular Carcinoma Cells via Inhibition of Nf-?b P65 and Wnt/?-Catenin in Vitro, Mar Drugs, vol.13, issue.10, pp.6064-6081, 2015.

A. Masoudi, « Neuroprotective effects of astaxanthin in a rat model of spinal cord injury, Behav. Brain Res, vol.329, pp.104-110, 2017.

M. M. Al-amin, « The antioxidant effect of astaxanthin is higher in young mice than aged: a region specific study on brain, Metab Brain Dis, vol.30, pp.1237-1246, 2015.

L. Xu, J. Zhu, W. Yin, and X. Ding, « Astaxanthin improves cognitive deficits from oxidative stress, nitric oxide synthase and inflammation through upregulation of PI3K/Akt in diabetes rat », Int J Clin Exp Pathol, vol.8, issue.6, pp.6083-6094, 2015.

L. Becue and . Le, Coenzyme Q10 a-t-il un intérêt comme adjuvant du traitement par statines ?, p.157

T. Hidaka, K. Fujii, I. Funahashi, N. Fukutomi, and K. Hosoe, Safety assessment of coenzyme Q10 (CoQ10) », Biofactors, vol.32, pp.199-208, 2008.

S. Greenberg and W. H. Frishman, Co-enzyme Q10: a new drug for cardiovascular disease, J Clin Pharmacol, vol.30, issue.7, pp.596-608

J. Garrido-maraver, Clinical applications of coenzyme Q10 », Front Biosci, vol.19, pp.619-633, 2014.

C. Schmelzer, I. Lindner, C. Vock, K. Fujii, and F. Döring, « Functional connections and pathways of coenzyme Q10-inducible genes: an in-silico study, IUBMB Life, vol.59, issue.10, pp.628-633, 2007.

, « The failure of mitochondria leads to neurodegeneration: Do mitochondria need a jump start? -PubMed -NCBI

J. M. Cooper, L. V. Korlipara, P. E. Hart, J. L. Bradley, and A. H. Schapira, « Coenzyme Q10 and vitamin E deficiency in Friedreich's ataxia: predictor of efficacy of vitamin E and coenzyme Q10 therapy », Eur. J. Neurol, vol.15, pp.1371-1379

S. Golbidi, S. A. Ebadi, and E. I. Laher, « Antioxidants in the treatment of diabetes, Curr Diabetes Rev, vol.7, issue.2, pp.106-125, 2011.

J. Liu, L. Wang, S. Zhan, and Y. Xia, « Coenzyme Q10 for Parkinson's disease », Cochrane Database Syst Rev, vol.12, p.8150, 2011.

L. A. Horrocks and Y. K. Yeo, « Health benefits of docosahexaenoic acid (DHA) », Pharmacol. Res, vol.40, issue.3, pp.211-225, 1999.

G. Philippe, J. Alessandri, A. Pierre, F. Pifferi, and L. Monique, Les rôles physiologiques majeurs exercés par les acides gras polyinsaturés (AGPI) », Oléagineux, Corps gras, Lipides, vol.12, 2005.

M. Hennebelle, « Acides gras polyinsaturés n-3 (AGPI n-3) e prévention des dommages cérébraux induits par un stress chronique, p.417

G. Burdge and P. Calder, « Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults », Reproduction, nutrition, development, vol.45, pp.581-97, 2005.

Y. Shi and P. Burn, « Lipid metabolic enzymes: emerging drug targets for the treatment of obesity, Nat Rev Drug Discov, vol.3, issue.8, pp.695-710, 2004.

J. P. Schuchardt, I. Schneider, H. Meyer, J. Neubronner, C. Schacky et al., « Incorporation of EPA and DHA into plasma phospholipids in response to different omega-3 fatty acid formulations -A comparative bioavailability study of fish oil vs. krill oil », Lipids in health and disease, vol.10, p.145, 2011.

P. P. Legrand, «. La, and . De-l'acide-docosahexaenoique-(dha, C22:6 n-3). ROLE DES DESATURASES, p.61

. «-nut2006sa0359ra, Consulté le: avr, vol.23, 2020.

, « Omega-3 DHA -Dossier complet -Bienfaits et posologie », Doctonat, juin 16, 2019.

W. S. Harris, « Omega-3 fatty acids and cardiovascular disease: a case for omega-3 index as a new risk factor », Pharmacol. Res, vol.55, issue.3, pp.217-223, 2007.

A. Macchia, « Omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: results of the FORWARD (Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation) trial », J. Am. Coll. Cardiol, vol.61, issue.4, pp.463-468

D. Mozaffarian and J. H. Wu, « (n-3) Fatty Acids and Cardiovascular Health: Are Effects of EPA and DHA Shared or Complementary?123 », J Nutr, vol.142, issue.3, pp.614-625, 2012.

T. D. O'connell, R. C. Block, S. P. Huang, and G. C. Shearer, « ?3-Polyunsaturated fatty acids for heart failure: Effects of dose on efficacy and novel signaling through free fatty acid receptor 4, J. Mol. Cell. Cardiol, vol.103, pp.74-92, 2017.

D. S. Siscovick, « Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the, American Heart Association, vol.135, pp.867-884, 2017.

L. Tavazzi, « Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, Lancet, vol.372, pp.61239-61247, 2008.

A. P. Defilippis, M. J. Blaha, and T. A. Jacobson, « Omega-3 Fatty acids for cardiovascular disease prevention, Curr Treat Options Cardiovasc Med, vol.12, issue.4, pp.365-380, 2010.

G. Colussi, C. Catena, M. Novello, N. Bertin, and L. A. Sechi,

, Relevance for cardiovascular outcomes », Nutrition, Metabolism and Cardiovascular Diseases, vol.27, pp.191-200, 2017.

F. Shahidi and P. Ambigaipalan, « Omega-3 Polyunsaturated Fatty Acids and Their Health Benefits, Annu Rev Food Sci Technol, vol.9, pp.345-381, 2018.

T. Takezaki, « Diet and lung cancer risk from a 14-year population-based prospective study in Japan: with special reference to fish consumption, Nutr Cancer, vol.45, issue.2, pp.160-167, 2003.

S. Mocellin, M. Briarava, and P. Pilati, « Vitamin B6 and Cancer Risk: A Field Synopsis and Meta-Analysis », JNCI J Natl Cancer Inst, vol.109, issue.3, p.2017

Y. Q. Chen, I. J. Edwards, S. J. Kridel, T. Thornburg, and I. M. Berquin, « Dietary fat-gene interactions in cancer, Cancer Metastasis Rev, vol.26, pp.535-551

S. C. Larsson, M. Kumlin, M. Ingelman-sundberg, and E. A. Wolk, « Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms, Am. J. Clin. Nutr, vol.79, issue.6, pp.935-945, 2004.

C. H. Maclean, « Effects of omega-3 fatty acids on cancer risk: a systematic review, JAMA, vol.295, issue.4, pp.403-415, 2006.

A. P. Simopoulos, « The importance of the ratio of omega-6/omega-3 essential fatty acids, Biomed. Pharmacother, vol.56, issue.8, pp.365-379, 2002.

P. Terry, P. Lichtenstein, M. Feychting, A. Ahlbom, and A. Wolk, « Fatty fish consumption and risk of prostate cancer, Lancet, vol.357, pp.4889-4892, 2001.

J. Zheng, X. Hu, Y. Zhao, J. Yang, and E. D. Li, « Intake of fish and marine n-3 polyunsaturated fatty acids and risk of breast cancer: meta-analysis of data from 21 independent prospective cohort studies, BMJ, vol.346, p.3706, 2013.

I. M. Berquin, « Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids, J. Clin. Invest, vol.117, issue.7, pp.1866-1875, 2007.

M. Sakai, « Arachidonic acid and cancer risk: a systematic review of observational studies, BMC Cancer, vol.12, p.606

E. Shahverdi, R. Niknam, and . Flaxseed, A Good Idea for Reduction of Mastalgia

, Risk of Breast Cancer », Focus on Sciences, vol.3, pp.1-7, 2017.

T. Dichwalkar, « Omega-3 Fatty Acid Grafted PAMAM-Paclitaxel Conjugate Exhibits Enhanced Anticancer Activity in Upper Gastrointestinal Cancer Cells, Macromol Biosci, vol.17, 2017.

, « Omega-3 fatty acids and dementia. -PubMed -NCBI, vol.23, 2020.

, Youth depression alleviation: the Fish Oil Youth Depression Study (YoDA-F): A randomized, double-blind, placebo-controlled treatment trial

, « Omega-3 treatment of childhood depression: a controlled, double-blind pilot study

M. P. Judge, O. Harel, and C. J. Lammi-keefe, « A docosahexaenoic acid-functional food during pregnancy benefits infant visual acuity at four but not six months of age, Lipids, vol.42, issue.2, pp.117-122, 2007.

M. Fleith and M. T. Clandinin, « Dietary PUFA for preterm and term infants: review of clinical studies, Crit Rev Food Sci Nutr, vol.45, issue.3, pp.205-229, 2005.

J. F. Gould, L. G. Smithers, and M. Makrides, « The effect of maternal omega-3 (n-3) LCPUFA supplementation during pregnancy on early childhood cognitive and visual development: a systematic review and meta-analysis of randomized controlled trials, Am. J. Clin. Nutr, vol.97, issue.3, pp.531-544, 2013.

, Encyclopedia of Food Chemistry, 2018.

S. E. Carlson, « DHA supplementation and pregnancy outcomes », Am. J. Clin. Nutr, vol.97, issue.4, pp.808-815, 2013.

J. Golding, C. Steer, P. Emmett, J. M. Davis, and J. R. Hibbeln, « High levels of depressive symptoms in pregnancy with low omega-3 fatty acid intake from fish, Epidemiology, vol.20, issue.4, pp.598-603, 2009.

S. R. Camelo, « Encapsulation de molécules hydrophobes par des structures bi-gels générées par prilling: relation structure-propriétés, p.254

J. Benoît, J. Richard, M. Venier-julienne, and . Microencapsulation, Ref : TIP453WEB -« Formulation, vol.10, 2013.

R. Challa, A. Ahuja, J. Ali, and R. K. Khar, Cyclodextrins in drug delivery: an updated review, vol.6, pp.329-357, 2005.

, « Les cyclodextrines : des écrins moléculaires

S. Weisse and «. Xi, , p.224

A. Gierden, « Administration par voie orale des composes BCS classe II: réponses galéniques au problème de la faible solubilité aqueuse, p.158

A. Gierden, « Administration par voie orale des composes BCS classe II: réponses galéniques au problème de la faible solubilité aqueuse, p.158

N. H. Shah, M. T. Carvajal, C. I. Patel, M. H. Infeld, and A. W. Malick, « Self-emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs, International Journal of Pharmaceutics, vol.106, issue.1, pp.90271-90273, 1994.

C. W. Pouton, Self-emulsifying drug delivery systems: assessment of the efficiency of emulsification, International Journal of Pharmaceutics, vol.27, issue.2, pp.335-348

, « Nanoparticle technology for drug delivery across the blood-brain barrier

Z. Li, H. Jiang, C. Xu, and L. Gu, « A review: Using nanoparticles to enhance absorption and bioavailability of phenolic phytochemicals, Food Hydrocolloids, vol.43, pp.153-164, 2015.

L. Jia, « Nanoparticle Formulation Increases Oral Bioavailability of Poorly Soluble Drugs: Approaches Experimental Evidences and Theory, Curr Nanosci, vol.1, issue.3, pp.237-243, 2005.

C. Solans, P. J. Izquierdo, J. Nolla, N. Azemar, M. García-celma et al., Current Opinion in Colloid & Interface Science, vol.10, pp.102-110, 2005.

T. Tadros, Emulsion Formation, Stability, and Rheology, pp.1-75, 2013.

H. Singh, C. Kumar, N. Singh, S. Paul, and S. K. Jain, « Nanoencapsulation of docosahexaenoic acid (DHA) using a combination of food grade polymeric wall materials and its application for improvement in bioavailability and oxidative stability, Food Funct, vol.9, issue.4, pp.2213-2227, 2018.

Z. Feng, M. Li, Y. Wang, and M. Zhu, « Astaxanthin from Phaffia rhodozyma: Microencapsulation with carboxymethyl cellulose sodium and microcrystalline cellulose and effects of microencapsulated astaxanthin on yogurt properties, vol.96, pp.152-160, 2018.

Q. Zhou, « Evaluation of the physicochemical stability and digestibility of microencapsulated esterified astaxanthins using in vitro and in vivo models, Food Chemistry, vol.260, pp.73-81, 2018.

L. Guan, « Water-dispersible astaxanthin-rich nanopowder: preparation, oral safety and antioxidant activity in vivo, Food Funct, vol.10, issue.3, pp.1386-1397, 2019.

K. Kaga, « Nanoparticle formation of PVP/astaxanthin inclusion complex by solutionenhanced dispersion by supercritical fluids (SEDS): Effect of PVP and astaxanthin Z-isomer content, The Journal of Supercritical Fluids, vol.136, pp.44-51, 2018.

S. F. Lockwood, S. O'malley, and G. L. Mosher, « Improved aqueous solubility of crystalline astaxanthin (3,3'-dihydroxy-beta, beta-carotene-4,4'-dione) by Captisol (sulfobutyl ether betacyclodextrin), J Pharm Sci, vol.92, issue.4, pp.922-926, 2003.

Y. Uekaji and K. Terao, « Coenzyme Q10 -gamma cyclodextrin complex is a powerful nutraceutical for anti-aging and health improvements, Biomed Res Clin Prac, vol.2, issue.1, 2017.

M. Milivojevi, L. Milivojevi, and M. Pro, Property Studies of Coenzyme Q10-Cyclodextrins complexes, p.7, 2009.

M. M. Fir, A. Smidovnik, L. Milivojevic, J. Zmitek, and M. Prosek, « Studies of CoQ10 and cyclodextrin complexes: solubility, thermo-and photo-stability, J Incl Phenom Macrocycl Chem, vol.64, issue.3, pp.225-232, 2009.

Y. Uekaji, « Micelle formation of coenzyme Q10 with dipotassium glycyrrhizate using inclusion complex of coenzyme Q10 with ?-cyclodextrin », J Phys Chem B, vol.118, pp.11480-11486, 2014.

J. Zmitek, « Relative bioavailability of two forms of a novel water-soluble coenzyme Q10, Ann. Nutr. Metab, vol.52, issue.4, pp.281-287, 2008.

P. Balakrishnan, « Enhanced oral bioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems », Int J Pharm, vol.374, issue.2, pp.66-72, 2009.

T. R. Kommuru, B. Gurley, M. A. Khan, and I. K. Reddy, « Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment », Int J Pharm, vol.212, issue.2, pp.233-246, 2001.

H. Sakaguchi, N. Haraguchi, Y. Oda, and F. Ueda, « Development of Self-emulsifying DHA Formulation, p.5

X. Meng, Y. Zu, X. Zhao, Q. Li, and S. Jiang, Sang, « Characterization and pharmacokinetics of coenzyme Q10 nanoparticles prepared by a rapid expansion of supercritical solution process, Pharmazie, vol.67, issue.2, pp.161-167

W. Y. Fung, M. T. Liong, and K. H. Yuen, « Preparation, in-vitro and in-vivo characterisation of CoQ10 microparticles: electrospraying-enhanced bioavailability », J. Pharm. Pharmacol, vol.68, issue.2, pp.159-169, 2016.

R. Walker, E. A. Decker, and D. J. Mcclements, « Development of food-grade nanoemulsions and emulsions for delivery of omega-3 fatty acids: opportunities and obstacles in the food industry, Food Funct, vol.6, issue.1, pp.42-55, 2015.

R. Libinaki and P. D. Gavin, « Changes in Bioavailability of Omega-3 (DHA) through Alpha-Tocopheryl Phosphate Mixture (TPM) after Oral Administration in Rats, Nutrients, vol.9, issue.9, 2017.

R. Couto, B. Seifried, P. Moquin, and F. Temelli, « Coenzyme Q10 solubility in supercritical CO2 using a dynamic system, Journal of CO2 Utilization, vol.24, pp.315-320, 2018.

N. Matsushita, T. Oshima, H. Takahashi, and Y. Baba, « Enhanced water dispersibility of coenzyme Q10 by complexation with albumin hydrolysate, J. Agric. Food Chem, vol.61, pp.5972-5978, 2013.

H. Zhou, « Novel lipid-free nanoformulation for improving oral bioavailability of coenzyme Q10, Biomed Res Int, vol.2014, p.793879, 2014.

B. Qin, « PEGylated Solanesol for Oral Delivery of Coenzyme Q10 », J. Agric. Food Chem, vol.65, pp.3360-3367, 2017.